Tyra Biosciences Inc. (TYRA) Statistics & Valuation Metrics - Stocknear

Tyra Biosciences Inc.

NASDAQ: TYRA · Real-Time Price · USD
12.97
0.43 (3.43%)
At close: Sep 26, 2025, 3:59 PM
12.97
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Tyra Biosciences Statistics

Share Statistics

Tyra Biosciences has 53.3M shares outstanding. The number of shares has increased by 0.84% in one year.

53.3M
0.84%
4.78%
81.83%
34.07M
643
0.25%

Short Selling Information

The latest short interest is 5.95M, so 11.17% of the outstanding shares have been sold short.

5.95M
11.17%
16.36%
26.23

Valuation Ratios

The PE ratio is -9.2 and the forward PE ratio is -5.75. Tyra Biosciences's PEG ratio is 1.35.

-9.2
-5.75
0
1005.6
2.32
-11.29
1.35
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tyra Biosciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 23.81, with a Debt / Equity ratio of 0.02.

23.81
23.81
0.02
-0.07
-0.09
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.44M
60
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -44.43% in the last 52 weeks. The beta is 1.1, so Tyra Biosciences's price volatility has been higher than the market average.

1.1
-44.43%
11.59
11.52
59.86
255,488

Income Statement

n/a
-519K
-104.18M
-86.48M
-85.96M
-86.48M
-1.51
Full Income Statement

Balance Sheet

The company has 91.97M in cash and 6.22M in debt, giving a net cash position of 85.74M.

91.97M
6.22M
85.74M
-251.31M
321.5M
288.38M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -69.77M and capital expenditures -664K, giving a free cash flow of -70.44M.

-69.77M
-664K
-70.44M
-1.23
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

TYRA does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for TYRA is $30.5, which is 135.2% higher than the current price. The consensus rating is "Buy".

$30.5
135.2%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

15.32
1